| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |